NMPA Approval

Levothyroxine Sodium Tablets

Approval Number

国药准字HJ20240061

Registration Date

June 28, 2024

Drug Information

Generic Name

左甲状腺素钠片

Dosage Form

片剂

Strength

100μg（以左甲状腺素钠计）

Drug Type

化学药品

Registration Date

June 28, 2024

Expiry Date

June 27, 2029

Company Address

14th km National Road 1, Kifissia GR-145 64，Greece

Company Address

Building B 14th km National Road 1, Kifissia GR-145 64 Greece

Empowering clinical research with data-driven insights and AI-powered tools.

左甲状腺素钠片 - NMPA 批准文号 | MedPath